Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules.
- 1 January 1997
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 42 (4) , 715-719
- https://doi.org/10.1023/a:1018839425118
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls.1996
- Omeprazole AdministrationAnnals of Pharmacotherapy, 1993
- Omeprazole: A Comprehensive ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993
- OmeprazoleNew England Journal of Medicine, 1991
- Controlling gastric pH: the impact of newer agents on the critically ill patient.1990
- Slow Omeprazole Metabolizers Are Also Poor S-Mephenytoin HydroxylatorsTherapeutic Drug Monitoring, 1990
- Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levelsDigestive Diseases and Sciences, 1986
- Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.Journal of Biological Chemistry, 1985
- Omeprazole: A Study of Its Inhibition of Gastric pH and Oral Pharmacokinetics After Morning or Evening DosageGastroenterology, 1985
- Development of an oral formulation of omeprazoleScandinavian Journal of Gastroenterology, 1985